Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients

Transplant Infectious Disease

Volumn 16, Issue 1, 2014, Pages 84-89

  Bert, F ^a   Larroque, B ^a   Dondero, F ^a   Durand, F ^a,b,c   Paugam Burtz, C ^a,c   Belghiti, J ^a,c   Moreau, R ^a,b   Nicolas Chanoine, M H ^a,b,c  

^a BEAUJON HOSPITAL   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Enterobacteriaceae; ESBL; Extended spectrum lactamase; Fecal carriage; Liver transplant; Spontaneous bacterial peritonitis

Indexed keywords

ENTEROBACTERIACEAE; ESBL; EXTENDED-SPECTRUM Β-LACTAMASE; FECAL CARRIAGE; LIVER TRANSPLANT; SPONTANEOUS BACTERIAL PERITONITIS;

ADULT; AMIKACIN; BETA-LACTAMASES; BETA-LACTAMS; CEFOXITIN; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; END STAGE LIVER DISEASE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; IMIPENEM; KLEBSIELLA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PENICILLANIC ACID; PERITONITIS; PIPERACILLIN; PREOPERATIVE PERIOD; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84893827681     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12169     Document Type: Article

References (24)

1. George DL, Arnow PM, Fox AS, et al. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 1991; 13: 387-396.
2. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995; 21: 1328-1336.
3. Singh N, Wagener MM, Obman A, Cacciarelli TW, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward Gram-negative bacteria as predominant pathogens. Liver Transplant 2004; 10: 844-849.
4. Bert F, Larroque B, Paugam-Burtz C, et al. Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transplant 2010; 16: 393-401.
5. García-Prado ME, Matia EC, Ciuro FP, et al. Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis. Transplantation 2008; 85: 1849-1854.
6. Shi SH, Kong HS, Xu J, et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis 2009; 11: 405-412.
7. Bert F, Larroque B, Paugam-Burtz C, et al. Pretransplant fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and infection after liver transplant, France. Emerg Infect Dis 2012; 18: 908-916.
8. Bert F, Galdbart J-O, Zarrouk V, et al. Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients. Clin Infect Dis 2000; 31: 1295-1299.
9. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871.
10. Garrec H, Drieux-Rouzet L, Golmard J-L, Jarlier V, Robert J. Comparison of nine phenotypic methods for detection of extended-spectrum β-lactamase production by Enterobacteriaceae. J Clin Microbiol 2011; 49: 1048-1057.
11. Communiqué de la Société Française de Microbiologie. Available at: http://www.sfm-microbiologie.org/UserFiles/file/CASFM/casfm_2010.pdf (accessed October 15, 2013).
12. Ben-Ami R, Schwaber MJ, Navon-Venezia S, et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006; 42: 925-934.
13. Peña C, Gudiol C, Tubau F, et al. Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalized patients. Clin Microbiol Infect 2006; 12: 279-284.
14. Harris AD, McGregor JC, Johnson JA, et al. Risk factors of colonization with extended-spectrum β-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007; 13: 1144-1149.
15. Friedmann R, Raveh D, Zartzer E, et al. Prospective evaluation of colonization with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hospital Epidemiol 2009; 30: 534-542.
16. Arnan M, Gudiol C, Calatayud L, et al. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 2011; 30: 355-360.
17. Wener KM, Schechner V, Gold HS, Wright SB, Carmeli Y. Treatment with fluoroquinolones or with β-lactam- β-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum β-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob Agents Chemother 2010; 54: 2010-2016.
18. Nicolas-Chanoine M-H, Jarlier V, Robert J, et al. Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-case-control study. PLoS One 2012; 7: e30498.
19. Fernández J, Acevedo J, Castro M, et al. Prevalence and risk factors by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012; 55: 1551-1561.
20. Tandon P, Delisle A, Topal JE, Garcia-Tsao G. High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center. Clin Gastroenterol Hepatol 2012; 10: 1291-1298.
21. Rodŕguez-Baño J, Ĺpez-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008; 62: 1142-1149.
22. Luvsansharav UO, Hirai I, Nakata A, et al. Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities. J Antimicrob Chemother 2012; 67: 1769-1774.
23. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
24. Kalpoe JS, Sonnenberg E, Factor SH, et al. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transplant 2012; 18: 468-474.